AICAR (AICA ribonucleoside)
Aicar · AICA ribonucleoside
AICAR commonly denotes AICA ribonucleoside in AMPK experiments. The abbreviation can cause confusion with its phosphorylated intracellular derivative, ZMP, so the chemical form must be explicit.
Reviewed September 2026
- Residues
- Not a peptide. not applicable: Amino-acid residue count is not applicable to this non-peptide molecular structure.
- Average mass
- 258.23 Da. verified: Reference form: AICA ribonucleoside/acadesine, C9H14N4O5; not phosphorylated AICAR/ZMP; formula C9H14N4O5. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not applicable. not applicable: A sequence-derived peptide pI is not applicable. Small-molecule ionization/pKa and solution pH are different properties; no small-molecule isoelectric model is asserted.
Reference details
| Residues | Not a peptide |
|---|---|
| Average mass | 258.23 Da |
| pI | Not applicable |
| Aliases | Aicar, AICA ribonucleoside |
|---|---|
| Research area | Metabolic |
Property basis and sources
These describe the reference compound or formulation, not identification or testing of the supplied lot.
Reference form: AICA ribonucleoside/acadesine, C9H14N4O5; not phosphorylated AICAR/ZMP. Not a sold-lot identity or measurement.
- Residues: Not a peptide (not applicable). Amino-acid residue count is not applicable to this non-peptide molecular structure. Residues source 1
- Average mass: 258.23 Da (verified). Reference form: AICA ribonucleoside/acadesine, C9H14N4O5; not phosphorylated AICAR/ZMP; formula C9H14N4O5. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement. Average mass source 1
- pI: Not applicable (not applicable). A sequence-derived peptide pI is not applicable. Small-molecule ionization/pKa and solution pH are different properties; no small-molecule isoelectric model is asserted. pI source 1
Reference scope and linked records
Reference type: Non-peptide small molecule.
This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.
Catalogue context: Aicar. The product retains its own name and specification; this link does not certify equivalence to published study material.
Related references
Sources and their scope
- AICA ribonucleoside: a specific method for activating AMPK in intact cells?. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.
About AICAR (AICA ribonucleoside)
Identity and context
The classic cellular study distinguishes the supplied ribonucleoside from the monophosphorylated material that accumulates inside cells. The two are not interchangeable analytical standards, even though they are closely linked in the experimental mechanism.
Reference classification
Non-peptide small molecule. The linked catalogue product is Aicar. This reference does not independently authenticate the material supplied.
Storage and handling
Analytical specification
Request confirmation of ribonucleoside versus phosphorylated nucleotide and identify any salt or hydrate. Match the assay standard to that form rather than assigning a peptide sequence to the acronym.
Storage and experimental handling
Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| What the source examines | The investigators studied rat hepatocytes and isolated adipocytes. They reported activation of AMPK and changes in lipid-related pathways after exposure to AICA ribonucleoside. The paper frames the compound as a tool for investigating kinase-regulated processes in intact cells. | Source context |
| What cannot be inferred | Cellular activation of an energy-sensing pathway is not evidence of improved human endurance or a general exercise replacement. The current catalogue name Aicar alone does not certify which chemical form is supplied. | Evidence limits |
References
Sources used for the data on this page, checked September 2026.
- AICA ribonucleoside: a specific method for activating AMPK in intact cells?Primary source for the reference discussion; not lot-specific product evidence.
Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.